Juan Luciano appointed to Eli Lilly board
December 16, 2015Medical Communications Eli Lilly
The board of directors of Eli Lilly has elected Juan Luciano as a new member, effective February 1 2016. Luciano …
AstraZeneca to acquire Takeda’s respiratory franchise
December 16, 2015Manufacturing and Production, Research and Development AstraZeneca, China, Takeda, investment, respiratory
AstraZeneca and Takeda have agreed a multi-million pound deal for AZ to acquire the Japanese firm’s core respiratory business, including …
Pharma deals crucial to cutting R&D costs
December 16, 2015Research and Development GlobalData, R&D, drug development, pharma, research and development
With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster …
Pharma companies warned on patent box changes
December 16, 2015Research and Development R&D, patent box, pharma, research and development, tax
Proposed Government changes to legislation will require businesses to track and trace all R&D expenditure if they want to continue …
More breakthroughs in cancer pose the question: Who pays for them?
December 16, 2015Research and Development Cancer, drug access, immunotherapy, oncology
The molecular revolution over the last decade has done much to help turn cancer into an illness that can be …
NICE rejects BMS cancer drug in draft guidance
December 16, 2015Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, NHS, NICE, lung cancer, nivolumab, non small cell lung cancer, non-small cell lung cancer, opdivo
In draft guidance, NICE has chosen not to recommend Bristol-Myers Squibb’s Opdivo for the treatment of locally advanced or metastatic …
NICE says no to NHS funding for Kadcyla
December 16, 2015Research and Development, Sales and Marketing Breast Cancer Now, Kadcyla, NHS, NICE, Roche, advanced breast cancer, breast cancer
NICE has turned down Roche’s application for NHS funding for Kadcyla as a treatment for a type of advanced breast …
Precious Cells Group appoints David Huse in expansion push
December 15, 2015Medical Communications, Research and Development Stem cells, precious cells group
Precious Cells Group, a UK-based international provider of stem cell storage and related technologies, has announced the appointment of commercial …
Amgen buys back rights to three drugs from GSK
December 15, 2015Research and Development, Sales and Marketing Amgen, GSK
Amgen has announced that it will reacquire the rights to three products in 48 countries from GSK, as it seeks …
AstraZeneca invests £75m to future-proof production facilities
December 15, 2015Manufacturing and Production AstraZeneca, manufacturing, production
AstraZeneca says it will invest £75m to future-proof a key production facility in Macclesfield, Cheshire. The upgrade to the 48-year-old …
Pharma giants Sanofi and Boehringer negotiate deal to swap assets
December 15, 2015Business Services, Manufacturing and Production, Sales and Marketing Andreas Barner, Boehringer, Boehringer Ingelheim, Merial, Sanofi, olivier brandicourt
Two of the world’s biggest pharma companies – Sanofi and Boehringer Ingelheim – have entered into exclusive negotiations to swap …
GSK in malaria collaboration with Comic Relief
December 15, 2015Manufacturing and Production Comic Relief, GSK, corporate social responsibility, csr, malaria
GSK and UK-based charity Comic Relief have launched a five-year partnership to fight malaria and improve health in five countries …
Bristol-Myers Squibb chooses UCLA as latest research partner
December 14, 2015Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, University of California Los Angeles, rare malignancies, ucla
Pharma firm Bristol-Myers Squibb is entered into a new collaboration agreement with the University of California Los Angeles (UCLA) as …
Ablynx sets focus on pharma collaborations
December 14, 2015Manufacturing and Production, Research and Development Ablynx, collaboration, nanobodies, partnership
Drug development companies should prioritise strategic pharma collaborations to keep up with the next wave of immuno-oncology treatments, the chief …
Mirror. Signal. Merger. How to deal with a pharma takeover
December 14, 2015Manufacturing and Production, Medical Communications, Sales and Marketing Deals, acquisition, buyouts, mergers, takeovers
So 2015 has been a record year for M&A in the pharma industry.The Financial Times has called this “the most …
AstraZeneca in $5bn Acerta buyout talks
December 14, 2015Sales and Marketing Acerta Pharma, AstraZeneca, acalabrutinib, acquisitions, blood cancer, buyout, chronic lymphocytic leukaemia, mergers, takeover
AstraZeneca has confirmed it is in negotiations to buy cancer drug developer Acerta Pharma BV for more than $5 billion …
Roche lung cancer drug Alecensa gets rapid US approval
December 14, 2015Sales and Marketing Alecensa, FDA, Genentech, Roche, accelerated approval, alectinib, lung cancer, non-small cell lung cancer
The US health watchdog has approved Alecensa, a drug for people with certain types of non-small cell lung cancer manufactured …
Novartis earns provisional NICE yes for Entresto
December 11, 2015Sales and Marketing Entresto, NICE, Novartis, chronic heart failure, heart failure
NICE has indicated it is likely to recommend Entresto, a novel drug manufactured by Novartis, as a treatment option for …
M&A activity drives record year for pharma outsourcing deals
December 11, 2015Sales and Marketing Covance, M&A, MA, labcorp, outsourcing
A drastic increase pharma industry in M&A activity has propelled the value of pharmaceutical outsourcing deals from $9.9 billion in …
Eisai’s Halaven shown to restrict further cancer metastasis
December 11, 2015Research and Development, Sales and Marketing Eisai, Halaven, Merck, keytruda
New data presented by Eisai supports the previously shown ability of Halaven (eribulin) to reverse epithelial-to-mesenchymal transition, the process by …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
